Bone loss in patients with rheumatoid arthritis: Results from a population-based cohort of 366 patients followed up for two years

Arthritis and Rheumatism

Volumn 46, Issue 7, 2002, Pages 1720-1728

  Haugeberg, Glenn ^a,d   Ørstavik, Ragnhild E ^a   Uhlig, Till ^a   Falch, Jan A ^b   Halse, Johan I ^c   Kvien, Tore K ^a  

^a DIAKONHJEMMET HOSPITAL   (Norway)

^b AKER UNIVERSITY HOSPITAL   (Norway)

^c Osteoporosis Clinic   (Norway)

^d Vest Agder Central Hospital   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRHEUMATIC AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCITONIN; CALCIUM; CORTICOSTEROID; VITAMIN D;

ADULT; AGED; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL EXAMINATION; CONTROLLED STUDY; CORTICOSTEROID THERAPY; DIET SUPPLEMENTATION; DUAL ENERGY X RAY ABSORPTIOMETRY; FEMALE; FOLLOW UP; HIP; HORMONE SUBSTITUTION; HUMAN; LIFESTYLE; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; OSTEOLYSIS; OSTEOPOROSIS; POPULATION RESEARCH; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; RISK FACTOR; SPINE; TREATMENT OUTCOME; VITAMIN SUPPLEMENTATION;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS; ARTHRITIS, RHEUMATOID; BONE DENSITY; BONE RESORPTION; CALCITONIN; CALCIUM; DENSITOMETRY, X-RAY; DIPHOSPHONATES; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; VITAMIN D;

EID: 0036062467     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/art.10408     Document Type: Article

References (44)

1. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: Results from 394 patients in the Oslo County Rheumatoid Arthritis register
2. Reduced bone mineral density in male rheumatoid arthritis patients: Frequencies and associations with demographic and disease variables in ninety-four patients in the Oslo County Rheumatoid Arthritis Register
3. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis
4. Clinical practice guidelines for the diagnosis and management of osteoporosis
5. Guidelines for the prevention and therapy of glucocorticoid-induced osteoporosis
6. Generalised bone loss in patients with early rheumatoid arthritis
7. Longitudinal bone mineral density changes in early rheumatoid arthritis
8. Effects of low dose corticosteroids on bone mass in rheumatoid arthritis: A longitudinal study
9. Low incidence of osteoporosis in a two year follow-up of early community based patients with rheumatoid arthritis
10. Factors influencing bone loss in rheumatoid arthritis: A longitudinal study
11. Vertebral bone mineral density changes in female rheumatoid arthritis patients treated with low-dose methotrexate
12. Prednisone treatment of elderlyonset rheumatoid arthritis: Disease activity and bone mass in comparison with chloroquine treatment
13. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease
14. Data driven attempt to create a clinical algorithm for identification of women with rheumatoid arthritis at high risk of osteoporosis
15. The prevalence and severity of rheumatoid arthritis in Oslo: Results from a county register and a population survey
16. The incidence and severity of rheumatoid arthritis: Results from a county register in Oslo, Norway
17. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis
18. Sicca symptoms, saliva and tear production, and disease variables in 636 patients with rheumatoid arthritis
19. Modified disease activity scores that include twenty-eight-joint counts: Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis
20. Statistical methods for assessing agreement between two methods of clinical measurement
21. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update
22. The diagnosis of osteoporosis
23. Threefold increased risk of hip fractures with rheumatoid arthritis in Central Finland
24. Rheumatoid arthritis, corticosteroid therapy and hip fracture
25. Risk of vertebral fracture in women with rheumatoid arthritis
26. Risk of vertebral fracture and relationship to bone mineral density in steroid treated rheumatoid arthritis
27. Bone mineral density measured by dualenergy x-ray absorptiometry in normal men
28. Dual-energy x-ray absorptiometry in normal women: A cross-sectional study of 717 Finnish volunteers
29. Cross-sectional versus longitudinal evaluation of bone loss in men and women
30. Effect of hormone replacement therapy on bone mass in rheumatoid arthritis patients treated with and without steroids
31. Intermittent etidronate therapy to prevent corticosteroidinduced osteoporosis
32. Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis
33. Risedronate therapy prevents corticosteroid-induced bone loss: A twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study
34. Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: A cross sectional study
35. Prevention of corticosteroid-induced osteoporosis: Results of a patient survey
36. Prevention of corticosteroid-induced osteoporosis in inpatients recently discharged from a tertiary teaching hospital
37. A four-year randomized controlled trial of hormone replacement and bisphosphonate, alone or in combination, in women with postmenopausal osteoporosis
38. Addition of alendronate to ongoing hormone replacement therapy in the treatment of osteoporosis: A randomized, controlled clinical trial
39. Effect of combined risedronate and hormone replacement therapies on bone mineral density in postmenopausal women
40. Increase of bone mineral density and anabolic variables in patients with rheumatoid arthritis resistant to methotrexate after cyclosporin A therapy
41. Users of low-dose glucocorticoids have increased bone loss rates: A longitudinal study
42. Low dose long-term corticosteroid therapy in rheumatoid arthritis: An analysis of serious adverse events
43. Limited bone loss due to corticosteroids: A systematic review of prospective studies in rheumatoid arthritis and other diseases
44. Individual smallest detectable difference in bone mineral density measurements